241 related articles for article (PubMed ID: 31505704)
1. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
[TBL] [Abstract][Full Text] [Related]
2. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
[TBL] [Abstract][Full Text] [Related]
3. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
5. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
6. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
[TBL] [Abstract][Full Text] [Related]
7. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
Baş F; Kayserili H; Darendeliler F; Uyguner O; Günöz H; Yüksel Apak M; Atalar F; Bundak R; Wilson RC; New MI; Wollnik B; Saka N
J Clin Res Pediatr Endocrinol; 2009; 1(3):116-28. PubMed ID: 21274396
[TBL] [Abstract][Full Text] [Related]
8. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
[TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
[TBL] [Abstract][Full Text] [Related]
11. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
[TBL] [Abstract][Full Text] [Related]
13. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations.
Wang R; Yu Y; Ye J; Han L; Qiu W; Zhang H; Liang L; Gong Z; Wang L; Gu X
Steroids; 2016 Apr; 108():47-55. PubMed ID: 26804566
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
[TBL] [Abstract][Full Text] [Related]
15. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
16. CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation.
Abid F; Tardy V; Gaouzi A; El Hessni A; Morel Y; Chabraoui L
Clin Chem Lab Med; 2008; 46(12):1707-13. PubMed ID: 18973462
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.
Su L; Yin X; Cheng J; Cai Y; Wu D; Feng Z; Liu L
Clin Chim Acta; 2018 Nov; 486():142-150. PubMed ID: 30048636
[TBL] [Abstract][Full Text] [Related]
18. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
Fanis P; Skordis N; Phylactou LA; Neocleous V
Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
[TBL] [Abstract][Full Text] [Related]
19. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Finkielstain GP; Chen W; Mehta SP; Fujimura FK; Hanna RM; Van Ryzin C; McDonnell NB; Merke DP
J Clin Endocrinol Metab; 2011 Jan; 96(1):E161-72. PubMed ID: 20926536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]